Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.21.1 (
chymotrypsin
)
10,938
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Soluble proteins from porcine brain were divided into two packs: (1) proteins which pass freely through CM52-cellulose, and (2) proteins retained on CM52. Each of these two packs of proteins was fractionated on preparative flat-bed isoelectrofocusing gel in the range of pH 2-12. Native
FKBP-25
and its truncated forms were found among other proteins retained on CM52-cellulose. Immunoblotting with anti-
FKBP-25
showed two bands in the range 27-30 kDa, one due to unmodified
FKBP-25
and other due to
FKBP-25
mixed with high-mobility group II protein (HMG-II). Selective immunostaining with anti-
FKBP-25
antibodies of proteins which were not retained on CM52-cellulose showed several bands within the range of pI 7-5 and mass of 23 +/- 2 kDa. These fractions of proteins were next resolved on two-dimensional gels and immunostained with anti-
FKBP-25
antibodies. Six proteins in the pI range 7-5 were detected. Edman degradation of
alpha-chymotrypsin
digests of the major spot suggests that it contains the GTP-binding protein Rab5 co-migrating with guanylyl kinase, whereas MALDI-TOF showed that a residual content of
FKBP-25
may be also associated with these two proteins. A residual quantity of
FKBP-25
was also associated with the phosphatidylethanolamine-binding protein which is abundant in the brain.
...
PMID:Mammalian FKBP-25 and its associated proteins. 1090 Jan 28